p53 pathway dysfunction in AML: beyond TP53 mutations

被引：5
|
作者：
Post, Sean M. [1 ]
Kornblau, Steven M. [1 ]
Quintas-Cardama, Alfonso [1 ]
机构：
[1] TCR2 Therapeut, Cambridge, MA 02142 USA
来源：
ONCOTARGET | 2017年 / 8卷 / 65期
关键词：
TP53; Mdm2; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; ADULTS;
D O I：
10.18632/oncotarget.22713
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：108288 / 108289
页数：2
相关论文
共 50 条
  • [31] Characterization of myeloid malignancies with TP53 mutations and comparison to P53 expression by immunohistochemical staining methods
    Karner, Kristin H.
    Kohan, Jessica L.
    Tripp, Sheryl R.
    Salama, Mohamed E.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (02) : E35 - E37
  • [32] Inhibition of TP53 Mutant Oral Cancer by Reactivating p53
    Kang, Yei-Jin
    Kim, Dae-Won
    Che, Xiangguo
    Choi, Je-Yong
    Kim, Seong-Gon
    APPLIED SCIENCES-BASEL, 2022, 12 (12):
  • [33] Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia
    A Carter
    K Lin
    P D Sherrington
    M Atherton
    K Pearson
    A Douglas
    A Burford
    V Brito-Babapulle
    E Matutes
    D Catovsky
    A R Pettitt
    Leukemia, 2006, 20 : 737 - 740
  • [34] Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia
    Carter, A
    Lin, K
    Sherrington, PD
    Atherton, M
    Pearson, K
    Douglas, A
    Burford, A
    Brito-Babapulle, V
    Matutes, E
    Catovsky, D
    Pettitt, AR
    LEUKEMIA, 2006, 20 (04) : 737 - 740
  • [35] Somatic Mutations in TP53 Identified in T-Cells of Patients with TP53-mutated AML
    Issa, Ghayas C.
    Bidikian, Aram
    Ayoub, Edward
    Wang, Feng
    Mohanty, Vakul
    Leighton, Jake
    Wu, Xiaogang
    Patsilevas, Tallie
    Alaniz, Zoe
    Zarka, Jabra
    Kanagal-Shamanna, Rashmi
    Daver, Naval
    Futreal, Andy
    Konopleva, Marina
    Navin, Nicholas
    Zhang, Jianhua
    Chen, Ken
    Andreeff, Michael
    BLOOD, 2022, 140 : 6267 - 6269
  • [36] Irradiation potentiates p53 phosphorylation and p53 binding to the promoter and coding region of the TP53 gene
    Legartova, Sona
    Fagherazzi, Paolo
    Goswami, Pratik
    Brazda, Vaclav
    Lochmanova, Gabriela
    Koutna, Irena
    Bartova, Eva
    BIOCHIMIE, 2023, 204 : 154 - 168
  • [37] TP53 or Not TP53: That Is the Question
    Green, Steven D.
    Zeidner, Joshua F.
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5235 - 5237
  • [38] Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance
    Dundr, Pavel
    Hajkova, Nikola
    Bartu, Michaela Kendall
    Cibula, David
    Drozenova, Jana
    Fabian, Pavel
    Fadare, Oluwole
    Fruhauf, Filip
    Hausnerova, Jitka
    Hojny, Jan
    Laco, Jan
    Lax, Sigurd F.
    Matej, Radoslav
    Mehes, Gabor
    Michalkova, Romana
    Nemejcova, Kristyna
    Singh, Naveena
    Stolnicu, Simona
    Svajdler, Marian
    Zimas, Tomas
    McCluggage, W. Glenn
    Struzinska, Vana
    PATHOLOGY, 2023, 55 (06) : 785 - 791
  • [39] Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
    Barekati, Zeinab
    Radpour, Ramin
    Kohler, Corina
    Zhang, Bei
    Toniolo, Paolo
    Lenner, Per
    Lv, Qing
    Zheng, Hong
    Zhong, Xiao Yan
    HUMAN MOLECULAR GENETICS, 2010, 19 (15) : 2936 - 2946
  • [40] TP53 mutations, p53 protein expression and EGFR expression in pediatric malignant astrocytomas and glioblastomas.
    Molenaar, WM
    Dam, A
    Fock, JM
    van den Borg, E
    Hofstra, RW
    BRAIN PATHOLOGY, 2000, 10 (04) : 691 - 691
12345